Our Investors
3i is a world leader in private equity and venture capital.
The company’s focus is on Buyouts, Growth Capital and Venture Capital and invests across Europe, the USA and Asia. Competitive advantage comes from its international network and the strength and depth of business relationships. These underpin the value 3i delivers to its portfolio and to shareholders.
3i’s Venture Capital business invests in scaleable early and late stage businesses. 3i’s VC team currently manage investments across Europe, USA, Asia and Israel, valued in excess of $1 billion. 3i’s VC investment fall into four main industry sectors, including healthcare, telecommunications, software and electronics/semiconductors. In the last twelve months, 3i’s VC healthcare team invested in TransMedics, Zonare, Small Bone Innovations, Carmel Pharma, Ulthera, Endosense and Triage Wireless.
